scholarly journals Detection of functional deterioration in glaucoma by trend analysis using comprehensive overlapping clusters of locations

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Stuart K. Gardiner ◽  
Steven L. Mansberger

Abstract Detecting rapid visual field deterioration is crucial for individuals with glaucoma. Cluster trend analysis detects visual field deterioration with higher sensitivity than global analyses by using predefined non-overlapping subsets of visual field locations. However, it may miss small defects that straddle cluster borders. This study introduces a comprehensive set of overlapping clusters, and assesses whether this further improves progression detection. Clusters were defined as locations from where ganglion cell axons enter the optic nerve head within a θ° wide sector, centered at 1º intervals, for various θ. Deterioration in eyes with or at risk of glaucomatous visual field loss was “detected” if ≥ Nθ clusters had deteriorated with p < pCluster, chosen empirically to give 95% specificity based on permuting the series. Nθ was chosen to minimize the time to detect subsequently-confirmed deterioration in ≥ 1/3rd of eyes. Times to detect deterioration were compared using Cox survival models. Biannual series were available for 422 eyes of 214 participants. Predefined non-overlapping clusters detected subsequently-confirmed change in ≥ 1/3rd of eyes in 3.41 years (95% confidence interval 2.75–5.48 years). After equalizing specificity, no criteria based on comprehensive overlapping clusters detected deterioration significantly sooner. The quickest was 3.13 years (2.69–4.65) for θ° = 20° and Nθ = 25, but the comparison with non-overlapping clusters had p = 0.672. Any improvement in sensitivity for detecting deterioration when using a comprehensive set of overlapping clusters was negated by the need to maintain equal specificity. The existing cluster trend analysis using predefined non-overlapping clusters provides a useful tool for monitoring visual field progression.

2004 ◽  
Vol 45 (8) ◽  
pp. 2613 ◽  
Author(s):  
Jost B. Jonas ◽  
Peter Martus ◽  
Folkert K. Horn ◽  
Anselm Ju¨nemann ◽  
Mathias Korth ◽  
...  

2005 ◽  
Vol 139 (6) ◽  
pp. 1062-1066 ◽  
Author(s):  
Andrew G. Lee ◽  
M. Bridget Zimmerman

2019 ◽  
Vol 97 (S263) ◽  
Author(s):  
Ryan Lee Bartlett ◽  
Bethany E Frost ◽  
Nick White ◽  
James R Fergusson ◽  
James E Morgan ◽  
...  

2001 ◽  
Vol 29 (6) ◽  
pp. 352-358 ◽  
Author(s):  
William Eric Sponsel ◽  
John Shoemaker ◽  
Yolanda Trigo ◽  
Josepha Mensah ◽  
Rajiv Rugwani ◽  
...  

1998 ◽  
Vol 76 (3) ◽  
pp. 273-277 ◽  
Author(s):  
Constance Nduaguba ◽  
Seyda Ugurlu ◽  
Joseph Caprioli

2003 ◽  
Vol 81 (3) ◽  
pp. 253-259 ◽  
Author(s):  
Kiyoshi Yaoeda ◽  
Motohiro Shirakashi ◽  
Atsushi Fukushima ◽  
Shigeo Funaki ◽  
Haruko Funaki ◽  
...  

2019 ◽  
Author(s):  
Venkata R. M. Chavali ◽  
Naqi Haider ◽  
Sonika Rathi ◽  
Vrathasha Vrathasha ◽  
Teja Alapati ◽  
...  

AbstractGlaucoma is a group of progressive optic neuropathies that share common biological and clinical characteristics including irreversible changes to the optic nerve and visual field loss caused by death of retinal ganglion cells (RGCs). The loss of RGCs manifests as characteristic cupping or optic nerve degeneration, resulting in visual field loss in patients with Glaucoma. Published studies on in vitro RGC differentiation from stem cells utilized classical RGC signaling pathways mimicking retinal development in vivo. Although many strategies allowed for the generation of RGCs, increased variability between experiments and lower yield hampered the cross comparison between individual lines and between experiments. To address this critical need, we developed a reproducible chemically defined in vitro methodology for generating retinal progenitor cell (RPC) populations from iPSCs, that are efficiently directed towards RGC lineage. Using this method, we reproducibly differentiated iPSCs into RGCs with greater than 80% purity, without any genetic modifications. We used small molecules and peptide modulators to inhibit BMP, TGF-β (SMAD), and canonical Wnt pathways that reduced variability between iPSC lines and yielded functional and mature iPSC-RGCs. Using CD90.2 antibody and Magnetic Activated Cell Sorter (MACS) technique, we successfully purified Thy-1 positive RGCs with nearly 95% purity.


Sign in / Sign up

Export Citation Format

Share Document